Menu Search
Equities

Pharma Equity Group A/S

PEGAc:EBT

Pharma Equity Group A/S

Actions
  • Price (DKK)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in DKKView more

In 2023, Pharma Equity Group A/S increased its cash reserves by 9.41%, or 364.00k. Cash Flow from Financing totalled 17.06m or -- of revenues. In addition the company used 16.62m for operations while cash used for investing totalled 73.00k.
Cash flow per share-0.0291
Price/Cash flow per share--
Book value per share0.0253
Tangible book value per share0.0118
More ▼

Balance sheet in DKKView more

Pharma Equity Group A/S has a Debt to Total Capital ratio of 45.35%, a higher figure than the previous year's 0.21%.
Current ratio1.92
Quick ratio--
Total debt/total equity0.8297
Total debt/total capital0.4535
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.